Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189653
DOI: 10.1016/j.bbcan.2026.189653 ↗At a glance
Übersichtsarbeit in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Written by Nuo Xu and 4 co-authors. Institution: Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China. Major MEDLINE topics: Neoplasms, Protein Processing, Post-Translational, Amino Acids. Cited 2 times so far (Crossref); 212 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Metabolic reprogramming is a hallmark of cancer, characterized by significant alterations in amino acid metabolism to support rapid proliferation and survival. Post-translational modifications (PTMs) have become key regulatory centers that convert oncogenic signals into metabolic changes. This review systematically examines the interplay between canonical PTMs, including phosphorylation, ubiquitination, acetylation, and methylation, and recently recognized metabolite-sensitive PTMs, including O-GlcNAcylation, lactylation, succinylation, crotonylation, and β-hydroxybutyrylation, in regulating key enzymes and transporters involved in amino acid metabolism. We describe how oncogenic pathways such as PI3K/AKT/mTOR and MYC induce metabolic changes through PTMs, and how amino acid-derived metabolites, in turn, feedback to influence signaling through "metabolite/PTM/signal" loops. Additionally, we emphasize how the PTM-amino acid metabolism axis influences the tumor microenvironment, particularly regarding immune suppression and the remodeling of the extracellular matrix. Finally, we review current clinical and preclinical therapeutic strategies that target PTM-modifying enzymes and PTM-dependent metabolic pathways. Although there are technical and biological challenges, focusing on this axis offers a promising avenue for developing personalized cancer treatments.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
- Department of Interventional Radiology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China. Electronic address: zhaohui800@163.co.
- Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China. Electronic address: wenjiezheng@ntu.edu.cn.
Funding
- National Natural Science Foundation of China
Cite
APA
Xu, N., Shao, J., Jiang, L., Zhao, H., & Zheng, W. (2026). Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189653. https://doi.org/10.1016/j.bbcan.2026.189653
Vancouver
Xu N, Shao J, Jiang L, Zhao H, Zheng W. Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189653. doi:10.1016/j.bbcan.2026.189653
BibTeX
@article{Xu2026,
author = {Xu, Nuo and Shao, Jiayu and Jiang, Lihan and Zhao, Hui and Zheng, Wenjie},
title = {Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189653},
doi = {10.1016/j.bbcan.2026.189653}
}
EUVIMED